Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery - Observed weight loss was 17% at 28 days, a 25% ...

If these findings are applicable to humans, it suggests a novel method of treating MS and other autoimmune diseases with ...

Brenus Pharma has announced the publication of a scientific article describing its new "off-the-shelf" cancer treatment in "Frontiers in Oncology" Section Cancer Immunity and Immunotherapy. Brenus' ...

Interleukin-10 promotes the formation of microcirculatory defects in the brain associated with cognitive impairment in a mouse model of type 1 diabetes. This Review discusses the incidence ...

New research suggests the seasonal shift to winter could have serious long-term consequences, especially for our children.

Model developed in study will pave way for more discovery about important but mysterious process Ben Emery, Ph.D., and ...

distasonis peptide and that P. distasonis can enhance type 1 diabetes development in the the mouse model, we have to prove that this enhancement is directly related to the peptide,” Altindis said. To ...

Ankita, whose ongoing research focuses on accelerating the healing of diabetic foot ulcers, explained that high blood sugar ...

Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal ...

Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...